Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 707,913 | 280,909 | 194,719 | 616,931 | 123,490 |
| Marketable Securities | 1,603,120 | 973,129 | 512,281 | 325,443 | 459,361 |
| Receivables | 396,125 | 371,245 | 235,217 | 125,036 | 74,228 |
| Inventories | 216,903 | 135,991 | 98,102 | 51,628 | 39,280 |
| Income taxes - deferred | 84,839 | 53,047 | 197,567 | N/A | N/A |
| Other current assets | 34,925 | 13,692 | 0 | 50,000 | 0 |
| TOTAL | $3,092,208 | $1,849,694 | $1,265,898 | $1,183,760 | $707,759 |
| Non-Current Assets | |||||
| PPE Net | 242,568 | 223,106 | 198,200 | 67,727 | 62,828 |
| Other Non-Current Assets | 431,540 | 83,163 | 90,624 | 36,696 | 24,199 |
| TOTAL | $674,108 | $306,269 | $288,824 | $104,423 | $87,027 |
| Total Assets | $3,766,316 | $2,155,963 | $1,554,722 | $1,288,183 | $794,786 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60,206 | 181 | 139 | 194 | 1,492 |
| Accounts payable and accrued liabilities | 70,908 | 47,552 | 35,649 | 24,406 | 19,174 |
| Accrued Expenses | 70,441 | 53,016 | 47,631 | 28,574 | 30,626 |
| TOTAL | $465,163 | $253,453 | $185,895 | $104,892 | $80,117 |
| Non-Current Liabilities | |||||
| Long Term Debt | 240,650 | 234 | 323 | 273 | 389 |
| Deferred Revenues | 18,353 | 19,880 | 5,474 | 7,692 | 3,996 |
| Other Non-Current Liabilities | 0 | 0 | 345,000 | 595,000 | 254,591 |
| TOTAL | $273,375 | $31,638 | $365,853 | $611,950 | $262,232 |
| Total Liabilities | $738,538 | $285,091 | $551,748 | $716,842 | $342,349 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,849,139 | 1,799,527 | 1,710,246 | 1,588,027 | 1,551,994 |
| Common Shares | 460 | 449 | 426 | 198 | 193 |
| Retained earnings | 809,642 | -4,272 | -453,643 | -381,640 | -453,737 |
| Other shareholders' equity | 11,448 | -19,231 | 3,201 | 2,475 | 7,448 |
| TOTAL | $3,027,778 | $1,870,872 | $1,002,974 | $571,341 | $452,437 |
| Total Liabilities And Equity | $3,766,316 | $2,155,963 | $1,554,722 | $1,288,183 | $794,786 |